Skip to main content

News Archive

News Archive - School of Medicine

UC San Diego Health Joins Leading National Network Targeting Depressive Illnesses

September 30, 2015

UC San Diego Health has been designated a member of the National Network of Depression Centers (NNDC), a consortium of leading academic medical centers working to accelerate research, education and improved treatment options for people with depressive and bipolar illnesses. UC San Diego Health joins 22 other institutions in the nationwide nonprofit network.

“Top Docs” Continue to Raise the Bar at UC San Diego Health

September 29, 2015

The votes are in and more than 100 physicians from UC San Diego Health were named “Top Docs” in the annual San Diego Magazine “Physicians of Exceptional Excellence” annual survey. These physicians represent 41 diverse specialties, from family medicine, surgery and oncology to obstetrics, cardiology and emergency medicine.

NCI Renews Funding for San Diego Universities, Community Health Centers to Work Together

September 28, 2015

A collaborative program aimed at reducing the burden of cancer among Hispanic/Latinos in San Diego and Imperial counties through research and community outreach has received a $13 million grant from the National Cancer Institute (NCI), part of the National Institutes of Health. The five-year grant renews funding for a partnership started in 2008 between San Diego State University and Moores Cancer Center at UC San Diego Health.

NFL Legend Advocates for Prostate Cancer Research on September 30

September 25, 2015

The third annual Breakfast with Champions is scheduled for Wednesday, September 30 from 8:00 to 10:00 a.m. at the La Jolla Country Club. The event, which is open to the public, features a presentation by nine-time Pro Bowl safety and analyst for the NFL on FOX, John Lynch. All proceeds will benefit prostate cancer research at Moores Cancer Center at UC San Diego Health.

New Grant Will Fund Collaborative Effort to Build Reproducible Assays To Model Autism

September 22, 2015

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Strong Student Test Scores Place Skaggs School of Pharmacy at UC San Diego in Top 10

September 22, 2015

In 2014, only 10 of the nation’s 132 pharmacy schools achieved a 100 percent pass rate on first-time attempts at the North American Pharmacist Licensure Examination (NAPLEX). The University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences was one of them, passing all 54 students who took the exam for the first time.

Albert La Spada Receives Harrington Scholar Award to Combat Neurodegenerative Disease

September 21, 2015

Albert La Spada, MD, PhD, professor of pediatrics, cellular and molecular medicine and neurosciences at University of California, San Diego School of Medicine, has received a 2015 Harrington Scholar award to advance his work on a therapy for Spinocerebellar ataxia type 7 (SCA7), a rare but devastating neurological disorder that can lead to blindness and progressive loss of physical coordination.

GERD Study Offers Minimally Invasive Procedure at No Cost

September 21, 2015

Approximately 20 million Americans will experience some type of gastroesophageal reflux disease, or GERD, in their lives. In some cases, patients suffer resulting heart burn or acid regurgitation so severe that they require surgery to repair damage to their esophagus. A clinical trial at UC San Diego Health is using a new, FDA-approved device that reconstructs the esophagus through the mouth and requires no incisions.

Down Syndrome Research Untangles Therapeutic Possibilities for Alzheimer’s

September 17, 2015

More than five million Americans are living with Alzheimer’s disease (AD). Of them, 400,000 also have Down syndrome. Both groups have similar looking brains with higher levels of the protein beta amyloid. In fact, patients with Down syndrome develop the abnormal protein at twice the rate. Results of a pilot study confirms the pathogenic role of beta amyloid in dementia as seen in both AD and Down syndrome.

Reduced Heart Rate Variability May Indicate Greater Vulnerability to PTSD

September 10, 2015

A prospective longitudinal study of U.S. Marines suggests that reduced heart rate variability – the changing time interval between heartbeats – may be a contributing risk factor for post-traumatic stress disorder (PTSD). The findings are reported in the September 9 online issue of JAMA Psychiatry by researchers at the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System.
Category navigation with Social links